Navigation Links
Amsterdam Molecular Therapeutics Announces Negative Equity Position
Date:12/14/2011

ay also have a detrimental effect on those programs still ongoing. In the event that additional cash inflows are not secured, AMT may not be able to continue as a going concern and would therefore be likely to go into insolvency.

The Management of AMT has been in contact with NYSE Euronext. In accordance with Euronext Amsterdam Notice 2011-001, NYSE Euronext will at this time not impose listing measures concerning the Company's negative equity position as long as the Company complies with the (continuing) disclosure requirements set out in paragraph 3 of Euronext Amsterdam Notice 2011-011. This is without prejudice to NYSE Euronext's right to impose listing measures if, in its opinion, facts or developments arise or have arisen with respect to a security which preclude an unconditional continuance of the official listing as provided in Rule 6903/1 Rule Book I. The full text of Euronext Amsterdam Notice 2011-001 in both Dutch and English can be found through the following link: http://europeanequities.nyx.com/sites/europeanequities.nyx.com/files/euronext_amsterdam_-_notice_2011-001.pdf.

In view of its negative net equity position, the Company shall shortly convene a general meeting of shareholders to discuss the measures to be taken in accordance with section 2:108a of the Dutch civil code.

About Amsterdam Molecular Therapeutics

AMT is a world leader in the development of human gene based therapies. AMT has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. Using adeno-associated viral (AAV) derived vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design and validate probably the world's first stable and scalable AAV manufacturing platform. This proprietary pl
'/>"/>

SOURCE Amsterdam Molecular Therapeutics (AMT) B.V
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Amsterdam Molecular Therapeutics Provides Business Update for the Third Quarter 2011
2. Amsterdam Molecular Therapeutics Provides Operations Update & Strategic Review of Pipeline
3. Amsterdam Molecular Therapeutics Receives Opinion on Re-examination of Glybera® Marketing Authorisation Application
4. Amsterdam Molecular Therapeutics Licenses Additional Novel Gene Therapy Vectors from National Institutes of Health
5. Amsterdam Molecular Therapeutics Reports Half-Year Results 2011
6. Amsterdam Molecular Therapeutics Files Glybera® European Marketing Application for Re-examination
7. Amsterdam Molecular Therapeutics Appoints Dr. Carlos R. Camozzi as Chief Medical Officer
8. Amsterdam Molecular Therapeutics Successfully Lowers Cholesterol In Vivo With Enhanced Novel MicroRNA AAV Gene Therapy
9. Amsterdam Molecular Therapeutics Reports Half-Year Results 2010
10. Amsterdam Molecular Therapeutics Reports Full Year Results 2009
11. The University of Amsterdam Joins the MetaMiner Metabolic Diseases Project
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , January 15, 2014 A study has ... on the Formula 1 track could help to tackle the ... Technologies (MAT), Stowhealth (a GP surgery based in Stowmarket) and ... provider Simplyhealth. Telemetry technology, which is inspired by ...
(Date:1/15/2014)... 2014 DTS Language Services, Inc . ... Portal for Life Science organizations who need document translations. ... matter of their documents in advance with a selection of ... of translations, often a critical factor in clinical and scientific ...
(Date:1/15/2014)... TAIPEI , Jan. 15, 2014 TaiGen Biotechnology ... an exclusive agreement with R-Pharm, a leading Russian pharmaceutical ... in the Russian Federation , ... Commonwealth Independent States (CIS). Nemonoxacin is a novel antibiotic for ...
(Date:1/14/2014)...  3D Communications, a leading provider of strategic communications services to corporations ... in the United States and ... , JD, is returning to the firm,s Washington, D.C. ... after more than two years of service as Associate Commissioner for ...
Breaking Biology Technology:Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4DTS Improves Efficiency for Life Science Document Translations 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Former FDA Associate Commissioner Returns To 3D Communications 2
... Zentaris Inc.,(NASDAQ: AEZS , TSX: AEZ), a ... will announce its third quarter 2008,financial and operating ... a.m.,The Company will host a conference call and ... at 10:00 a.m., Eastern Time., Participants may ...
... -- China Shenghuo,Pharmaceutical Holdings, Inc. (Amex: ... is engaged in the research, development, manufacture, ... products,in the People,s Republic of China, today ... the American Stock Exchange) (the "Exchange") has ...
... Make Diabetes a Smaller Part of Life, BEDFORD, ... the leader in patch pump technology with its OmniPod(R),Insulin ... Part of Your Life, video contest. The competition begins ... all current OmniPod users.,Entrants are invited to create a ...
Cached Biology Technology:NYSE Alternext US Accepts China Shenghuo's Compliance Plan for Continued Listing 2NYSE Alternext US Accepts China Shenghuo's Compliance Plan for Continued Listing 3NYSE Alternext US Accepts China Shenghuo's Compliance Plan for Continued Listing 4Video: Insulet Unveils Video Contest for OmniPod Users 2Video: Insulet Unveils Video Contest for OmniPod Users 3
(Date:4/24/2014)... International Glossina Genome Initiative (IGGI) has produced the first ... morsitans . The blood-sucking insect is the sole transmitter ... sub-Saharan Africa. The vast store of genetic data will ... and provide insights into the tsetse fly,s unique biology. ... insect world: it feeds exclusively on the blood of ...
(Date:4/24/2014)... Publishing recently introduced Clinical OMICs ... application of OMICs technologies in clinical settings. These ... to transform medical care just as they revolutionized ... , "GEN,s editors and reporters have written about ... etc. etc. for years," said John Sterling, editor-in-chief ...
(Date:4/24/2014)... research led by Alison Allan, PhD, a scientist at ... why breast cancer often spreads or metastasizes to the ... cancer and the number two cause of cancer-related deaths ... traditional chemotherapy and radiation have a high success rate, ... conventional treatments fail. In particular, the lung is one ...
Breaking Biology News(10 mins):Genetic code of the deadly tsetse fly unraveled 2New study helps to explain why breast cancer often spreads to the lung 2
... NY In the neuromuscular disease called spinal muscular ... single gene mutation leads to serious damage in growing ... Now, in laboratory experiments, researchers at Cold Spring Harbor ... replenish the protein by activating an existing, slightly modified ...
... WI, APRIL 4, 2008 The American Society ... (CSSA), and Soil Science Society of America (SSSA) ... as part of the 2008 National Student Recognition ... the Societies news magazine. The 2008 National ...
... some people are born with silver spoons in their ... of the animal world, according to research done in ... of female red squirrels in Kluane, Yukon, revealed that ... spring temperature experienced between birth and weaning could reflect ...
Cached Biology News:Cold Spring Harbor Laboratory scientists devise potential approach to treat spinal muscular atrophy 2Outstanding undergraduates recognized in agronomy, crop, soil, and environmental sciences 2
Request Info...
NATIVE RAT OSTEOCALCIN...
... Chicken polyclonal to Opsin 1 ( Abpromise ... Antigen: Synthetic peptide: YEDSTHASIFTYT, corresponding to amino ... and synthetic peptide corresponding to amino acids 18/30 ... and used as immunogen. Entrez ...
EnzChek Ultra Xylanase Assay Kit *500 assays*...
Biology Products: